Recent advances in factor XII(a) inhibitors: an updated patent landscape (2020-present)

Research output: Contribution to a Journal (Peer & Non Peer) › Article › peer-review

Original language	English
Journal	Expert Opinion on Therapeutic Patents
DOIs	https://doi.org/10.1080/13543776.2026.2627911
Publication status	Published - 5 Feb 2026

Access to Document

@article{612eb5ccc74942e69866cca4db4d64ad,

title = "Recent advances in factor XII(a) inhibitors: an updated patent landscape (2020-present)",

author = "Kalinin, \{Dmitrii V.\}",

year = "2026",

month = feb,

day = "5",

doi = "10.1080/13543776.2026.2627911",

language = "English",

journal = "Expert Opinion on Therapeutic Patents",

issn = "1354-3776",

publisher = "Taylor and Francis Ltd.",

}

TY - JOUR

T1 - Recent advances in factor XII(a) inhibitors: an updated patent landscape (2020-present)

AU - Kalinin, Dmitrii V.

PY - 2026/2/5

Y1 - 2026/2/5

UR - https://doi.org/10.1080/13543776.2026.2627911

U2 - 10.1080/13543776.2026.2627911

DO - 10.1080/13543776.2026.2627911

M3 - Article

SN - 1354-3776

JO - Expert Opinion on Therapeutic Patents

JF - Expert Opinion on Therapeutic Patents

ER -